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Background: Although there is an increasing number of eosinophilic gastrointestinal disorders (EGID)
cases including eosinophilic esophagitis (EoE) and eosinophilic gastroenteritis (EGE), being reported
globally, no systematic reviews have been conducted to elucidate the racial differences in these disorders.
We aimed to show the racial differences, especially among Caucasians and Asians, in the risk of EoE and
EGE.
Methods: We conducted a systematic review using PubMed in September 2012. All case reports and case
series on EGID that involved human subjects and described race or ethnicity, as well as pathological
ﬁndings, were included. For the comparison of reported cases between Caucasians and Asians, a chi-
squared test was used.
Results: Among the 687 studies found in PubMed, 121 studies fulﬁlled the eligibility criteria. In total,
2621 patients were reviewed. Among Caucasian EGID patients, 94% had EoE; while among Asian EGID
patients, 72% had EGE (p < 0.001). Among EoE, Asians were signiﬁcantly less likely to have dysphagia and
heartburn, but more likely to have vomit and abdominal pain, compared to Caucasians (p < 0.001).
Further, among EGE, Asians were signiﬁcantly more likely to have eosinophil-inﬁltrated colon than
Caucasians (OR: 3.22, 95% conﬁdence interval [CI]: 1.60e7.04), but were less likely to have eosinophil-
inﬁltrated stomach (OR: 0.29, 95% CI: 0.17e0.49).
Conclusions: We found that EoE occurs more frequently in Caucasian EGID patients than Asian EGID
patients, while the reverse is true for EGE. Also, racial disparities in symptoms and eosinophil-inﬁltrated
tissues were observed. Our ﬁndings suggest further genetic and environmental studies to elucidate the
etiology of EGID.
Copyright © 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Eosinophilic gastrointestinal disorders (EGID) are chronic in-
ﬂammatory disorders characterized by primary eosinophilic
inﬁltration of the gastrointestinal (GI) tract without any known
causes of eosinophilia such as parasitic infections, drug reactions,
and malignancy.1 EGID include eosinophilic esophagitis (EoE)
and eosinophilic gastroenteritis (EGE); EoE involves only the
esophagus, while EGE involves any part of the GI tract.1e3 These
disorders have been gaining attention in recent years as severaledicine, National Research
ura, Setagaya-ku, Tokyo 157-
ra).
ety of Allergology.
rgology. Production and hosting by Elsestudies reported a rapid rise in their prevalence; in particularly
EoE, which saw a 35-fold rise in Philadelphia, USA, and an 18-fold
rise in Australia, over the past ten years.4,5 However, the exact
etiology of EGID has yet to be elucidated, although the role of
food-derived antigen or inﬂammatory mediators such as IL-5, IL-
13, thymic stromal lymphopoietin and eotaxin-3 have been
described.6e9
Globally, there seems to be a disparity in the incidence rate of
the type of EGID being reported; EoE cases have been reported
more frequently in Western countries,10e18 while EGE were more
likely in Asian countries.19e64 Although racial and ethnic disparities
in the severity and prevalence of immune and allergic disorders
such as asthma and atopic dermatitis have been demonstrated
before,65,66 no such association has not been evaluated for EGID. To
that end, we conducted a systematic review on EGID, focusing on
Caucasian and Asian populations.vier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
687 records identified through 
database (PubMed) search
188 excluded on the basis of 
title and abstract
499 full-text articles assessed 
for eligibility
121 articles included in this 
review
319, no race or ethnicity information
46, possible duplicated study
6, no pathology
6, not EGID cases
1 review
Fig. 1. Flow diagram of literature search.
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Literature reviews
All research articles involving human EoE or EGE cases, which
described race or ethnicity, and pathological ﬁndings, were
included for the study. Articles that were not published in English,
had no abstract, or in the form of a review were excluded. A liter-
ature search was conducted on PubMed on 22nd September, 2012.
The following search strings were used: “eosinophilic esophagitis”
[All Fields], “allergic esophagitis” [All Fields], “eosinophilic esoph-
agitis” [All Fields], “eosinophilic gastroenteritis” [All Fields],
“allergic gastroenteritis” [All Fields]; together with the following
search conditions: English [lang], NOT Review [ptyp], AND has
abstract [text]. Initial eligibility screening based on title and ab-
stract was performed independently in a standardized manner by
two reviewers (Jun Ito and Takeo Fujiwara). Subsequently, a full-
text screening was conducted for further assessment. Discrep-
ancies between reviewers were resolved by consensus. Despite
ethnicity not being clearly described in the literature, study sub-
jects from South Korea, China, Taiwan, and Japan were regarded as
Asian based on the ethnically homogenous nature of the coun-
tries.67 If an identical set of subjects were used in multiple articles,
the literature which had more detailed information or larger
sample size was selected.
Analyses
Through full-text screening of eligible articles, we extracted and
compiled patients' characteristics and clinical information. For
single case reports or case series, information of each patient was
recorded. If a study showed only aggregated sample characteristics
and clinical information, aggregated data were used. Finally, we
calculated total number of subjects and divided them by race,
diagnosis, age and diagnostic criteria.
To stratify subjects by age, samples 18 years old or older were
categorized as adults, while those less than 18 years old were
categorized as children.68 Samples from four studies which showed
only aggregated sample data conducted in children's hospitals were
assigned for the children category; two studies had mean age 6.4
and 11.4 years old, respectively,69,70 and the other two involved
samples of 18 and 21 years old, respectively.71,72 One study which
also showed only aggregated sample data with a 15-year-old pa-
tient among 42 EGE patients was assigned for the adult category, as
the mean age of the samples was 48.2 years old, with the oldest
patient being 72 years old.43,68
The difference in diagnostic criteria for EGID was considered as
it may affect the number of reported cases. At present, a peak count
of 15 eosinophils per high-power ﬁeld (eos/HPF) is the minimum
required threshold for the diagnosis of EoE,73 with some studies
using >20 or >24 eos/HPF.4,8,74 In this review, EoE samples were
divided into three groups based on either peak or mean number of
eosinophils:15 eos/HPF,>20 eos/HPF, and others or unknown. For
EGE, no standards for diagnosis exist; however, the majority of
studies on EGE follow a Talley criteria75 which requires the pres-
ence of gastrointestinal symptoms and eosinophil inﬁltration of
one or more areas of the gastrointestinal tract (with no evidence of
parasitic or extraintestinal disease). In view of this, we divided EGE
samples into two groups; one which met Talley's criteria, and the
other one which neither meet the criteria nor mention the diag-
nostic criteria used.
A chi-squared test was used to compare the reported cases of
EoE or EGE between Caucasians and Asians. Further, a logistic
regression was conducted to calculate odds ratios (OR) of Asians
who had GI symptoms (dysphagia, heartburn, vomit, abdominalpain and diarrhea), relative to Caucasians, among cases of EoE, EGE,
and overall patients. The ORs of Asians who had eosinophilic
inﬁltration for each GI tract (esophagus, stomach, small intestine
and colon), relative to EGE Caucasians, were also calculated. All
analyses were performed using the STATA SE statistical package,
version 12 (Stata Corp., College Station, TX, USA).Results
Our search identiﬁed 687 studies, of which 499 were deemed
relevant on the basis of their titles and abstracts. Of these, 378
studies were subsequently excluded: 319 studies were without
information on race or ethnicity; 46 studies had samples that were
possibly duplicated; six studies had no pathological ﬁndings; six
studies comprised of subjects whose diagnosis were not of EGID;
and one study was a review article. Finally 121 studies were
included for further analysis (Fig 1). The number of publications
which included Caucasian patients and Asian patients was 59 and
70, respectively. In total, 2621 cases were obtained from these
studies (Table 1). The cases included patients ranging from infant to
elderly, with men more dominant for both EoE and EGE than
women. Across all races, more than half of the EoE patients were
diagnosed by the diagnostic criteria of >15 eos/HPF. For EGE, most
Asian patients were diagnosed by Talley's criteria, while the same
did not apply to Caucasians and other races. Among Caucasians,
94% of EGID patients had EoE, while among the Asian patients, 72%
had EGE (p < 0.001).
There were signiﬁcant differences in the number of reported
cases of EoE and EGE between Caucasian and Asian samples
(Table 2). Caucasian is dominant among EoE, while Asian is domi-
nant among EGE for both in total and adult (both p < 0.001). For
children, the percentage of Caucasian among EoE (97%) is higher
than among EGE (68%) (p < 0.001).
Table 3 shows the odds ratios of Asians relative to Caucasians in
having GI symptoms among EoE, EGE and EGID (i.e., considering
total EoE and EGE cases). For esophagus related symptoms in EoE
cases, Asians were 0.27 and 0.32 times less likely to have dysphagia
and heartburn, respectively, than Caucasians (95% conﬁdence in-
terval [CI], 0.16e0.47; and 0.15e0.62, respectively). On the other
hand, for stomach and lower GI tract related symptoms in EoE
Table 1
Characteristics of samples.
Race Diagnosis n (%) yAge range ySex (male %) Diagnostic criteria n (%) Reference
Caucasian EoE 1873 (93.2) 15e76 70.9 eos >15 HPF 989 (52.8) 10e14,71,84e95
eos >20 HPF 778 (41.5) 15,16,69,72,96e100
unknown 106 (5.7) 17,18,70,101,102
EGE 137 (6.8) 1e74 62.4 xTalley criteria 74 (54.0) 103e112
unknown 63 (46.0) 113e129
Asian EoE 105 (27.3) 11e83 70.4 eos >15 HPF 72 (68.6) 25,93e95,130e136
eos >20 HPF 30 (28.6) 69,72,96,98,100,137e140
unknown 3 (2.9) 101,141
EGE 279 (72.7) 0e72 55.4 xTalley criteria 244 (87.5) 19e44,103
unknown 35 (12.5) 45e64,117
zOthers EoE 215 (94.7) 39 NA eos >15 HPF 125 (58.1) 71,84e95
eos >20 HPF 76 (35.3) 69,72,96e100
unknown 14 (6.5) 70,101,102,142
EGE 12 (5.3) 3e56 66.7 xTalley criteria 2 ((16.7) 143,144
unknown 10 ((83.3) 57,117,120,145
EoE, eosinophilic esophagitis; EGE, eosinophilic gastroenteritis; eos, eosinophils; HPF, high-power ﬁeld; NA, not applicable.
y Only studies whereby the majority of samples (>95%) consisted of either Caucasians or Asians were included.
z Other ethnicities include Latin American and African.
x Presence of gastrointestinal symptoms and eosinophil inﬁltration of the gastrointestinal tract (with no evidence of parasitic or extraintestinal disease).
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and abdominal pain, respectively, than Caucasians (95% CI,
1.09e23.5; and 4.65e32.2, respectively). Among EGE cases, Asians
were 0.32 times less likely to experience vomiting than Caucasians
(95% CI, 0.19e0.54). In total cases, i.e. EGID cases, Asians were
signiﬁcantly less likely to have dysphagia and heartburn, and more
likely to have vomit, abdominal pain and diarrhea.
Further, among EGE, Asians are 0.29 times signiﬁcantly less
likely to have the stomach inﬁltrated by eosinophils (95% CI,
0.17e0.49), while their colons are 3.22 times signiﬁcantly more
likely to be inﬁltrated by eosinophils (95% CI, 1.60e7.04) compared
to those of Caucasians (Table 4).
Discussion
This systematic review revealed that among Asians, less EoE and
more EGE cases were reported compared to Caucasians. Further,
differences in GI symptoms were seen between Caucasians and
Asians, even after stratiﬁcation by EoE or EGE. Among EoE, Asians
are signiﬁcantly less likely to have dysphagia and heartburn
directly related to the esophagus, but are signiﬁcantly more likely
to have vomit and abdominal pain relatively related to the stomach
or the lower GI. Interestingly, among Asian EGE patients, the
stomach is less likely to be inﬁltrated by eosinophils, hence less
likely to experience vomiting than Caucasian EGE patients.
Conversely, the colon in Asian EGE patients is more likely to be
inﬁltrated by eosinophils, but lower GI symptoms are not signiﬁ-
cantly more likely to be seen compared to Caucasian EGE patients.
Helicobacter pylori infection is suspected to be one possible
etiology of EGID because it affects immune response, especially Th2
response and Th2-related cytokines such as IL-5, 13, as well as
eotaxins.6e8 Recently, two cross-sectional studies showed anTable 2
Reported cases of EoE and EGE among Caucasians and Asians.
Race All samples yChild (<18 y.o
EoE EGE xp value EoE
n (%) n (%) n (%)
Caucasian 1873 (94.7) 137 (32.9) 1014 (97.0)
Asian 105 (5.3) 279 (67.1) <0.001 31 (3.0)
EoE, eosinophilic esophagitis; EGE, eosinophilic gastroenteritis.
y Samples of four studies from children's hospitals whereby the oldest age was not ex
z Samples of a study whose age range was from 15 to 72 years old were included.
x Chi-squared test.inverse association of EGID with H. pylori.76,77 Thus, the prevalence
of H. pylori infection might explain the racial differences with
regards to the location of EGID (i.e. EoE or EGE). In Japan, the
prevalence of H. pylori infection among the 55e64 age group was
88%, while that in the US was 35%.78 Although a direct association
between H. pylori infection and EGE is yet to be uncovered, the
differences in prevalence and variation of the genotypes of H. pylori
between races79,80 may explain the racial disparities in the location
of EGID. At the same time, H. pylori infection may partly explain
why Asian EoE patients are less likely to experience heartburn.
Gastroesophageal reﬂux can be seen as a concomitant cause for
EoE, and there is an association of gastroesophageal reﬂux disease
with a particularly virulent genotype of H. pylori.81
A diversity in dietary habits between the two races could be
another possible explanation. According to the Food and Agricul-
ture Organization of the United Nations, total vegetables supply
quantity (kg/capita/yr) in Eastern Asia is more than double than
that of Northern America, while total meat supply quantity in North
America is more than double than that of Eastern Asia.82 These
dietary differences may be one reason of the variance of inﬂam-
matory site in the GI tract among races. Another possible expla-
nation is that genetic polymorphism or epigenetic change in GI
tract tissues may be associated with the racial differences in EGE.
Further studies investigating racial differences and dietary habits,
or immigration studies such as that of the Japanese acculturation
among immigrants in Hawaii,83 are warranted to elucidate the
mechanism of higher predisposition of EGE among Asians.
To date, the diagnosis and treatment of EGE cannot be deduced
as being more developed compared to EoE. As a greater area of the
GI tract is impaired in EGE than in EoE, the QOL of EGE patients is
more severely impacted, particularly in the form of malnutrition
with hypoproteinemia. In addition, topical therapy with less side.) zAdult (18 y.o.)
EGE xp value EoE EGE xp value
n (%) n (%) n (%)
58 (68.2) 859 (92.1) 79 (23.9)
27 (31.8) <0.001 74 (7.9) 252 (76.1) <0.001
actly 18 years old, or younger, were included.
Table 3
Odds ratios of Asians having GI symptoms among EoE and EGE patients, respectively, relative to Caucasian.
Dysphagia Heartburn Vomit Abdominal pain Diarrhea
n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI)
EoE
yCaucasian
(n ¼ 552)
426 (77.2) reference 215 (38.9) reference 6 (1.1) reference 10 (1.8) reference 5 (0.9) reference
yAsian (n ¼ 71) 34 (47.9) 0.27 (0.16e0.47)* 12 (16.9) 0.32 (015e0.62)* 4 (5.6) 5.43
(1.09e23.5)*
13 (18.3) 12.1
(4.65e32.2)*
0 (0) NA
EGE
yCaucasian
(n ¼ 92)
5 (5.4) reference 3 (3.3) reference 44 (47.8) reference 61 (66.3) reference 44 (47.8) reference
yAsian (n ¼ 276) 15 (5.4) 1.00 (0.33e3.62) 3 (1.1) 0.33 (0.04e2.49) 62 (22.5) 0.32
(0.19e0.54)*
179 (64.9) 0.94
(0.55e1.58)
138 (50.0) 1.09
(0.66e1.80)
Total
yCaucasian
(n ¼ 644)
431 (66.9) reference 218 (33.9) reference 50 (7.8) reference 71 (11.0) reference 49 (7.6) reference
yAsian (n ¼ 347) 49 (14.1) 0.08 (0.06e0.12)* 15 (4.3) 0.09 (0.05e0.15)* 66 (19.0) 2.79
(1.85e4.23)*
192 (55.3) 10.0
(7.14e14.0)*
138 (39.8) 8.02
(5.51e11.8)*
CI, conﬁdence interval; EoE, eosinophilic esophagitis; EGE, eosinophilic gastroenteritis; GI, gastrointestinal; NA, not applicable; OR, odds ratio.
y Only studies in which the majority of samples (>95%) consisted of either Caucasians or Asians were included.
* p < 0.05.
Table 4
Odds ratios of Asian EGE patients having eosinophilic inﬁltration in the esophagus, stomach, small intestine and colon, relative to Caucasian EGE patients.
Esophagus Stomach Small intestine Colon
n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI)
yCaucasian (n ¼ 92) 4 (4.3) reference 59 (64.1) reference 48 (52.2) reference 11 (12.0) reference
yAsian (n ¼ 276) 17 (6.2) 1.44 (0.45e6.05) 95 (34.4) 0.29 (0.17e0.49)* 166 (60.1) 1.38 (0.84e2.28) 84 (30.4) 3.22 (1.60e7.04)*
CI, conﬁdence interval; EGE, eosinophilic gastroenteritis; OR, odds ratio.
y Only studies in which the majority of samples (>95%) consisted of either Caucasians or Asians were included.
* p < 0.05.
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cannot be used for EGE. At present, the effects of dietary treatment,
a potent therapeutic method for EoE, are not fully understood for
EGE patients. Hence, there is a crucial need for guidelines for
diagnosis and treatment of EGE. At the same time, clinicians who
tend to EGID patients should consider the race and the country of
residence of the patients, as the affected area within the GI tract
may vary accordingly.
Several limitations to this study need to be addressed. First, the
diagnostic criteria and the quality of diagnosis were not uniﬁed.
Hence, there may be potential misclassiﬁcation. According to the
consensus recommendation of EoE diagnosis, biopsy specimens
should be obtained not only from various esophageal locations
along the length of the esophagus, but also from the lower GI tract,
to rule out other diseases.73 However, we found that not all studies
clearly stated all of the biopsy sites. In view of that, we are aware
that there may be cases that are not true EoE. For the diagnosis of
EoE, there are twomajor criteria for eosinophil counts. As shown in
Table 1, 41.5% of the Caucasian and 28.6% of the Asian EoE patients
were diagnosed by a more stringent criteria of 20 eos/HPF. As such,
there would have been patients who had EoE, but had eosinophil
counts of between 15 and 19 eos/HPF, being excluded from the
reports. In spite of that, this possible misclassiﬁcation does not
affect our ﬁnding of Caucasians being more likely to have EoE than
Asians. In fact, it would further afﬁrm our results.
Second, some studies did not report EoE or EGE cases stratiﬁed
by racial groups. As we selected studies in which the major racial
composite (>95%) of the samples was either that of Asians or
Caucasians, there may be a certain degree of misclassiﬁcation in
terms of race. However, the number of such cases was small (n¼ 6).
Therefore, the effect of this misclassiﬁcation is negligible.
In conclusion, we have demonstrated through a systematic re-
view that EoE is more likely to exist among Caucasian EGID patientsthan such patients of Asian descent, while the reverse is true for
EGE. Symptoms and eosinophil-inﬁltrated tissues related to the
esophagus are more likely to be found among Caucasian EGID pa-
tients, while symptoms and eosinophil-inﬁltrated tissues related to
the stomach or the lower GI tract are frequent in Asian EGID pa-
tients. These ﬁndings warrant further genetic and environmental
studies for the etiology of EGID. Furthermore, investigations from
the viewpoint of H. pylori infection, dietary habits, and genetic
predisposition using genome-wide association study, can be valu-
able in elucidating the etiology of EGID.
Acknowledgment
We would like to thank Dr. Julian Tang of the Department of
Education for Clinical Research, National Center for Child Health
and Development, for proofreading and editing this manuscript.
This study was supported by a grant from the Ministry of Health,
Labour and Welfare of Japan, Research for Intractable Diseases,
(H26-nanchi-ippan-048) to I.N.
Conﬂict of interest
The authors have no conﬂict of interest to declare.
Authors' contributions
TF and IN conceived and designed the study, JI conducted systematic review, JI
and RK collected data, JI analyzed and wrote the ﬁrst manuscript, TF and IN ﬁnalized
the manuscript. All authors read and approved the ﬁnal manuscript.
References
1. Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin
Immunol 2004;113:11e28. quiz 29.
2. Furuta GT, Forbes D, Boey C, Dupont C, Putnam P, Roy S, et al. Eosinophilic
gastrointestinal diseases (EGIDs). J Pediatr Gastroenterol Nutr 2008;47:234e8.
J. Ito et al. / Allergology International 64 (2015) 253e259 2573. Lucendo AJ. Eosinophilic diseases of the gastrointestinal tract. Scand J Gas-
troenterol 2010;45:1013e21.
4. Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E, et al.
Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastro-
enterol Hepatol 2005;3:1198e206.
5. Cherian S, Smith NM, Forbes DA. Rapidly increasing prevalence of eosinophilic
oesophagitis in Western Australia. Arch Dis Child 2006;91:1000e4.
6. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. IL-5 promotes eosinophil
trafﬁcking to the esophagus. J Immunol 2002;168:2464e9.
7. Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic esophagitis
by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology
2003;125:1419e27.
8. Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, et al.
Eotaxin-3 and a uniquely conserved gene-expression proﬁle in eosinophilic
esophagitis. J Clin Invest 2006;116:536e47.
9. Sherrill JD, Rothenberg ME. Genetic dissection of eosinophilic esophagitis
provides insight into disease pathogenesis and treatment strategies. J Allergy
Clin Immunol 2011;128:23e32. quiz 33e24.
10. Abu-Sultaneh SM, Durst P, Maynard V, Elitsur Y. Fluticasone and food allergen
elimination reverse sub-epithelial ﬁbrosis in children with eosinophilic
esophagitis. Dig Dis Sci 2011;56:97e102.
11. Batog C, Psevdos Jr G, Paniz-Mondolﬁ A, Srivastava S, Sharp VL. Eosinophilic
oesophagitis: an unsuspected aetiology for dysphagia in an HIV-positive pa-
tient. Int J STD AIDS 2010;21:842e4.
12. Engel MA, Raithel M, Amann K, Greess H, Hahn EG, Konturek PC. Rare coin-
cidence of eosinophilic esophagitis with esophageal stenosis and intramural
pseudodiverticulosis. Dig Liver Dis 2008;40:700e6.
13. Lindberg GM, Van Eldik R, Saboorian MH. A case of herpes esophagitis after
ﬂuticasone propionate for eosinophilic esophagitis. Nat Clin Pract Gastro-
enterol Hepatol 2008;5:527e30.
14. Zuber-Jerger I, Ratiu N, Kullman F. Long-lasting effect of endoscopic dilatation
of an esophageal stenosis due to eosinophilic esophagitis. J Gastrointestin Liver
Dis 2006;15:167e70.
15. Straumann A, Conus S, Grzonka P, Kita H, Kephart G, Bussmann C, et al. Anti-
interleukin-5 antibody treatment (mepolizumab) in active eosinophilic
oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut
2010;59:21e30.
16. Yan BM, Shaffer EA. Eosinophilic esophagitis: an overlooked entity in chronic
dysphagia. Nat Clin Pract Gastroenterol Hepatol 2006;3:285e9. quiz 281 p
following 293.
17. Lee RG. Marked eosinophilia in esophageal mucosal biopsies. Am J Surg Pathol
1985;9:475e9.
18. Nicholson AG, Li D, Pastorino U, Goldstraw P, Jeffery PK. Full thickness eosin-
ophilia in oesophageal leiomyomatosis and idiopathic eosinophilic oesophagitis.
A common allergic inﬂammatory proﬁle? J Pathol 1997;183:233e6.
19. Ashraf S, Ashraf I, Alkarawi M, Haleem A, Bzeizi K. Eosinophilic gastroenteritis
causing stenosis of bulbo-duodenal junction: medical and endoscopic man-
agement. BMJ Case Rep 2009. http://dx.doi.org/10.1136/bcr.03.2009.1641.
20. Cha JM, Lee JI, Joo KR, Shin HP. Eosinophilic gastroenteritis with eosinophilic
dermatitis. Yonsei Med J 2010;51:145e7.
21. Chen MJ, Chu CH, Lin SC, Shih SC, Wang TE. Eosinophilic gastroenteritis:
clinical experience with 15 patients. World J Gastroenterol 2003;9:2813e6.
22. Chou CH, Shin JS, Wu MH, Chow NH, Lin XZ. Eosinophilic gastroenteritis with
esophageal involvement. J Formos Med Assoc 1996;95:403e5.
23. Hui CK. Resolution of eosinophilic gastroenteritis after resection of uterine
leiomyomas. Singap Med J 2011;52:e217e9.
24. Kim HM, Woo JY. Enterobiliary ﬁstula as a complication of eosinophilic
gastroenteritis: a case report. Korean J Radiol 2008;9:275e8.
25. Kinoshita Y, Furuta K, Ishimaura N, Ishihara S, Sato S, Maruyama R, et al.
Clinical characteristics of Japanese patients with eosinophilic esophagitis and
eosinophilic gastroenteritis. J Gastroenterol 2013;48:333e9.
26. Lee CM, Changchien CS, Chen PC, Lin DY, Sheen IS, Wang CS, et al. Eosinophilic
gastroenteritis: 10 years experience. Am J Gastroenterol 1993;88:70e4.
27. Lee KJ, Hahm KB, Kim YS, Kim JH, Cho SW, Jie H, et al. The usefulness of Tc-
99m HMPAO labeled WBC SPECT in eosinophilic gastroenteritis. Clin Nucl
Med 1997;22:536e41.
28. Liao WH, Wei KL, Lin PY, Wu CS. A rare case of spontaneous resolution of
eosinophilic ascites in a patient with primary eosinophilic gastroenteritis.
Chang Gung Med J 2012;35:354e9.
29. Lin HH, Wu CH, Wu LS, Shyu RY. Eosinophilic gastroenteritis presenting as
relapsing severe abdominal pain and enteropathy with protein loss. Emerg
Med J 2005;22:834e5.
30. Murata A, Akahoshi K, Kouzaki S, Ogata D, Motomura Y, Matsui N, et al.
Eosinophilic gastroenteritis observed by double balloon enteroscopy and
endoscopic ultrasonography in the whole gastrointestinal tract. Acta Gastro-
enterol Belg 2008;71:418e22.
31. Nakahama H, Nakamura H, Kuribayashi K, Ihaku D, Ikeda I, Nishioka Y, et al.
Two cases of eosinophilic gastroenteritis associated with analgesic-induced
bronchial asthma. Respirology 1998;3:95e7.
32. Ong GY, Hsu CC, Changchien CS, Lu SN, Huang SC. Eosinophilic gastroenteritis
involving the distal small intestine and proximal colon. Chang Gung Med J
2002;25:56e61.
33. Otowa Y, Mitsutsuji M, Urade T, Chono T, Morimoto H, Yokoyama K, et al.
Eosinophilic gastroenteritis associated with multiple gastric cancer. Eur J
Gastroenterol Hepatol 2012;24:727e30.34. Oyaizu N, Uemura Y, Izumi H, Morii S, Nishi M, Hioki K. Eosinophilic gastro-
enteritis. Immunohistochemical evidence for IgE mast cell-mediated allergy.
Acta Pathol Jpn 1985;35:759e66.
35. Shin WG, Park CH, Lee YS, Kim KO, Yoo KS, Kim JH, et al. Eosinophilic enteritis
presenting as intussusception in adult. Korean J Intern Med 2007;22:13e7.
36. Suzuki S, Homma T, Kurokawa M, Matsukura S, Adachi M, Wakabayashi K,
et al. Eosinophilic gastroenteritis due to cow's milk allergy presenting with
acute pancreatitis. Int Arch Allergy Immunol 2012;158(Suppl. 1):75e82.
37. Takahashi T, Nakamura K, Nishikawa S, Tsuyuoka R, Suzuki A, Murakami M,
et al. Interleukin-5 in eosinophilic gastroenteritis. Am J Hematol 1992;40:
295e8.
38. Takeyama Y, Kamimura S, Suzumiya J, Oh K, Okumura M, Akahane H, et al.
Case report: eosinophilic colitis with high antibody titre against Ascaris suum.
J Gastroenterol Hepatol 1997;12:204e6.
39. Tien FM, Wu JF, Jeng YM, Hsu HY, Ni YH, Chang MH, et al. Clinical features and
treatment responses of children with eosinophilic gastroenteritis. Pediatr
Neonatol 2011;52:272e8.
40. Tsai MJ, Lai NS, Huang YF, Huang YH, Tseng HH. Allergic eosinophilic
gastroenteritis in a boy with congenital duodenal obstruction. J Microbiol
Immunol Infect 2000;33:197e201.
41. Yamada Y, Nishi A, Ebara Y, Kato M, Yamamoto H, Morita H, et al. Eosinophilic
gastrointestinal disorders in infants: a Japanese case series. Int Arch Allergy
Immunol 2011;155(Suppl. 1):40e5.
42. Yoda A, Takeshima F, Kadota K, Inoue K, Nakamichi S, Hayashi T, et al.
Eosinophilic enteritis: efﬁciency of the (13)c-acetate breath test for assessing
the disease activity. Intern Med 2012;51:2551e4.
43. Zhang L, Duan L, Ding S, Lu J, Jin Z, Cui R, et al. Eosinophilic gastroenteritis:
clinical manifestations and morphological characteristics, a retrospective
study of 42 patients. Scand J Gastroenterol 2011;46:1074e80.
44. Zhou HB, Chen JM, Du Q. Eosinophilic gastroenteritis with ascites and hepatic
dysfunction. World J Gastroenterol 2007;13:1303e5.
45. Bleibel F, Fragoza K, Faller GT. Acute eosinophilic ascites in a middle-aged
man. Case Rep Gastrointest Med 2012;2012:896523.
46. Bo Y. Observation of curative effect on eosinophilic gastroenteritis by treat-
ment with method of reinforcement of essence of the kidney. J Tradit Chin
Med 1996;16:186e9.
47. Haberkern CM, Christie DL, Haas JE. Eosinophilic gastroenteritis presenting as
ileocolitis. Gastroenterology 1978;74:896e9.
48. Hsu YQ, Lo CY. A case of eosinophilic gastroenteritis. Hong Kong Med J 1998;4:
226e8.
49. Imai E, Kaminaga T, Kawasugi K, Yokokawa T, Furui S. The usefulness of
99mTc-hexamethylpropyleneamineoxime white blood cell scintigraphy in a
patient with eosinophilic gastroenteritis. Ann Nucl Med 2003;17:601e3.
50. Ishido K, Tanabe S, Higuchi K, Sasaki T, Katada C, Azuma M, et al. Eosinophilic
gastroenteritis associated with giant folds. Dig Endosc 2010;22:312e5.
51. Keshavarzian A, Saverymuttu SH, Tai PC, Thompson M, Barter S, Spry CJ, et al.
Activated eosinophils in familial eosinophilic gastroenteritis. Gastroenterology
1985;88:1041e9.
52. Maeshima A, Murakami H, Sadakata H, Saitoh T, Matsushima T, Tamura J, et al.
Eosinophilic gastroenteritis presenting with acute pancreatitis. J Med
1997;28:265e72.
53. Matsushita M, Hajiro K, Morita Y, Takakuwa H, Suzaki T. Eosinophilic
gastroenteritis involving the entire digestive tract. Am J Gastroenterol
1995;90:1868e70.
54. Miyamoto T, Shibata T, Matsuura S, Kagesawa M, Ishizawa Y, Tamiya K.
Eosinophilic gastroenteritis with ileus and ascites. Intern Med 1996;35:779e82.
55. Miyazono T, Kawabata M, Higashimoto I, Koreeda Y, Iwakiri Y, Arimura K,
et al. Eosinophilic pneumonia with eosinophilic gastroenteritis. Intern Med
1999;38:450e3.
56. Park HS, Kim HS, Jang HJ. Eosinophilic gastroenteritis associated with food
allergy and bronchial asthma. J Korean Med Sci 1995;10:216e9.
57. Sheikh RA, Prindiville TP, Pecha RE, Ruebner BH. Unusual presentations of
eosinophilic gastroenteritis: case series and review of literature. World J
Gastroenterol 2009;15:2156e61.
58. Sun HL, Lue KH. Eosinophilic gastroenteritis in children-report of one case.
Asian Pac J Allergy Immunol 2001;19:221e3.
59. Suzuki J, Kawasaki Y, Nozawa R, Isome M, Suzuki S, Takahashi A, et al. Oral
disodium cromoglycate and ketotifen for a patient with eosinophilic gastro-
enteritis, food allergy and protein-losing enteropathy. Asian Pac J Allergy
Immunol 2003;21:193e7.
60. Tai YG, Liu JD, Lin KY, Chang JG, Wang CK, Siauw CP, et al. Eosinophilic
gastroenteritis with eosinophilic ascites: report of a case. J Formos Med Assoc
1990;89:901e4.
61. Takeyama J, Abukawa D, Miura K. Eosinophilic gastroenteritis with cyto-
megalovirus infection in an immunocompetent child. World J Gastroenterol
2007;13:4653e4.
62. Wang CS, Hsueh S, Shih LY, Chen MF. Repeated bowel resections for eosino-
philic gastroenteritis with obstruction and perforation. Case report. Acta Chir
Scand 1990;156:333e6.
63. Yamada Y, Kato M, Toki F, Watanabe M, Nishi A, Matsushita I, et al. Eosino-
philic gastrointestinal disorder in an infant with feeding dysfunction. Int Arch
Allergy Immunol 2012;158(Suppl. 1):83e6.
64. Fang RC, Ng KW, Hsueh SC, Jiang CF, Chung MT. Eosinophilic gastroenteritis:
report of two cases. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi
1987;20:154e62.
J. Ito et al. / Allergology International 64 (2015) 253e25925865. Gamble C, Talbott E, Youk A, Holguin F, Pitt B, Silveira L, et al. Racial differ-
ences in biologic predictors of severe asthma: data from the Severe Asthma
Research Program. J Allergy Clin Immunol 2010;126:1149e56. e1141.
66. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the
United States: data from the 2003 National Survey of Children's Health.
J Invest Dermatol 2011;131:67e73.
67. The World Factbook, Ethnic Groups. Central Intelligence Agency Web site.
Available at: https://www.cia.gov/library/publications/the-world-factbook/
ﬁelds/2075.html. Accessed October 4, 2013.
68. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, et al.
Eosinophilic esophagitis: updated consensus recommendations for children
and adults. J Allergy Clin Immunol 2011;128:3e20. e26; quiz 21e22.
69. Kagalwalla AF, Sentongo TA, Ritz S, Hess T, Nelson SP, Emerick KM, et al. Effect
of six-food elimination diet on clinical and histologic outcomes in eosinophilic
esophagitis. Clin Gastroenterol Hepatol 2006;4:1097e102.
70. Tantibhaedhyangkul U, Tatevian N, Gilger MA, Major AM, Davis CM. Increased
esophageal regulatory T cells and eosinophil characteristics in children with
eosinophilic esophagitis and gastroesophageal reﬂux disease. Ann Clin Lab Sci
2009;39:99e107.
71. Franciosi JP, Hommel KA, DeBrosse CW, Greenberg AB, Greenler AJ, Abonia JP,
et al. Quality of life in paediatric eosinophilic oesophagitis: what is important
to patients? Child Care Health Dev 2012;38:477e83.
72. Sorser SA, Barawi M, Hagglund K, Almojaned M, Lyons H. Eosinophilic
esophagitis in children and adolescents: epidemiology, clinical presentation
and seasonal variation. J Gastroenterol 2012;48:81e5.
73. Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, et al.
Eosinophilic esophagitis in children and adults: a systematic review and
consensus recommendations for diagnosis and treatment. Gastroenterology
2007;133:1342e63.
74. Croese J, Fairley SK, Masson JW, Chong AK, Whitaker DA, Kanowski PA, et al.
Clinical and endoscopic features of eosinophilic esophagitis in adults. Gas-
trointest Endosc 2003;58:516e22.
75. Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis:
a clinicopathological study of patients with disease of the mucosa, muscle
layer, and subserosal tissues. Gut 1990;31:54e8.
76. Dellon ES, Peery AF, Shaheen NJ, Morgan DR, Hurrell JM, Lash RH, et al. Inverse
association of esophageal eosinophilia with Helicobacter pylori based on
analysis of a US pathology database. Gastroenterology 2011;141:1586e92.
77. Furuta K, Adachi K, Aimi M, Ishimura N, Sato S, Ishihara S, et al. Case-control
study of association of eosinophilic gastrointestinal disorders with Heli-
cobacter pylori infection in Japan. J Clin Biochem Nutr 2013;53:60e2.
78. Epidemiology of, and risk factors for, Helicobacter pylori infection among
3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group.
Gut 1993;34:1672e6.
79. Shyu RY, Jiang SY, Lai CH, Hsu CT, Young TH, Yeh MY. High frequency of
cytotoxin-associated gene A in Helicobacter pylori isolated from asymptomatic
subjects and peptic ulcer patients in Taiwan. J Clin Gastroenterol 1998;27:54e9.
80. Yamaoka Y, Kato M, Asaka M. Geographic differences in gastric cancer inci-
dence can be explained by differences between Helicobacter pylori strains.
Intern Med 2008;47:1077e83.
81. Fallone CA, Barkun AN, Gottke MU, Best LM, Loo VG, Veldhuyzen van Zanten S,
et al. Association of Helicobacter pylori genotype with gastroesophageal
reﬂux disease and other upper gastrointestinal diseases. Am J Gastroenterol
2000;95:659e69.
82. Food and Agriculture Organization of the United Nations. FAOSTAT site.
Available at: http://faostat3.fao.org/faostat-gateway/go/to/home/E. Accessed
February 4, 2014.
83. Marmot MG, Syme SL. Acculturation and coronary heart disease in Japanese-
Americans. Am J Epidemiol 1976;104:225e47.
84. Bohm M, Malik Z, Sebastiano C, Thomas R, Gaughan J, Kelsen S, et al. Mucosal
eosinophilia: prevalence and racial/ethnic differences in symptoms and
endoscopic ﬁndings in adults over 10 years in an urban hospital. J Clin Gas-
troenterol 2012;46:567e74.
85. Dellon ES, Sheikh A, Speck O, Woodward K, Whitlow AB, Hores JM, et al.
Viscous topical is more effective than nebulized steroid therapy for patients
with eosinophilic esophagitis. Gastroenterology 2012;143:321e4. e321.
86. Gonsalves N, Yang GY, Doerﬂer B, Ritz S, Ditto AM, Hirano I. Elimination diet
effectively treats eosinophilic esophagitis in adults; food reintroduction
identiﬁes causative factors. Gastroenterology 2012;142:1451e9. e1451; quiz
e1414e55.
87. Kagalwalla AF, Amsden K, Shah A, Ritz S, Manuel-Rubio M, Dunne K, et al.
Cow's milk elimination: a novel dietary approach to treat eosinophilic
esophagitis. J Pediatr Gastroenterol Nutr 2012;55:711e6.
88. Moawad FJ, Veerappan GR, Lake JM, Maydonovitch CL, Haymore BR,
Kosisky SE, et al. Correlation between eosinophilic oesophagitis and aero-
allergens. Aliment Pharmacol Ther 2010;31:509e15.
89. Penﬁeld JD, Lang DM, Goldblum JR, Lopez R, Falk GW. The role of allergy
evaluation in adults with eosinophilic esophagitis. J Clin Gastroenterol
2010;44:22e7.
90. Ravi K, Katzka DA, Smyrk TC, Prasad GA, Romero Y, Francis DL, et al. Preva-
lence of esophageal eosinophils in patients with Barrett's esophagus. Am J
Gastroenterol 2011;106:851e7.
91. Ravi K, Talley NJ, Smyrk TC, Katzka DA, Kryzer L, Romero Y, et al. Low grade
esophageal eosinophilia in adults: an unrecognized part of the spectrum of
eosinophilic esophagitis? Dig Dis Sci 2011;56:1981e6.92. Ricker J, McNear S, Cassidy T, Plott E, Arnold H, Kendall B, et al. Routine
screening for eosinophilic esophagitis in patients presenting with dysphagia.
Ther Adv Gastroenterol 2011;4:27e35.
93. Dohil R, Newbury R, Fox L, Bastian J, Aceves S. Oral viscous budesonide is
effective in children with eosinophilic esophagitis in a randomized, placebo-
controlled trial. Gastroenterology 2010;139:418e29.
94. Gonsalves N, Policarpio-Nicolas M, Zhang Q, Rao MS, Hirano I. Histopathologic
variability and endoscopic correlates in adults with eosinophilic esophagitis.
Gastrointest Endosc 2006;64:313e9.
95. Sperry SL, Woosley JT, Shaheen NJ, Dellon ES. Inﬂuence of race and gender on
the presentation of eosinophilic esophagitis. Am J Gastroenterol 2012;107:
215e21.
96. Assa'ad AH, Gupta SK, Collins MH, Thomson M, Heath AT, Smith DA, et al. An
antibody against IL-5 reduces numbers of esophageal intraepithelial eosino-
phils in children with eosinophilic esophagitis. Gastroenterology 2011;141:
1593e604.
97. Eroglu Y, Lu H, Terry A, Tendler J, Knopes B, Corless C, et al. Pediatric eosin-
ophilic esophagitis: single-center experience in northwestern USA. Pediatr Int
2009;51:612e6.
98. Flood EM, Beusterien KM, Amonkar MM, Jurgensen CH, Dewit OE, Kahl LP,
et al. Patient and caregiver perspective on pediatric eosinophilic esophagitis
and newly developed symptom questionnaires*. Curr Med Res Opin 2008;24:
3369e81.
99. Patel NP, Bussler JF, Geisinger KR, Geisinger KF, Hill ID. Are pathologists
accurately diagnosing eosinophilic esophagitis in children? A 9-year single
academic institutional experience with interobserver observations. Int J Surg
Pathol 2011;19:290e6.
100. Spergel JM, Brown-Whitehorn TF, Beausoleil JL, Franciosi J, Shuker M,
Verma R, et al. 14 years of eosinophilic esophagitis: clinical features and
prognosis. J Pediatr Gastroenterol Nutr 2009;48:30e6.
101. Aceves SS, Bastian JF, Newbury RO, Dohil R. Oral viscous budesonide: a po-
tential new therapy for eosinophilic esophagitis in children. Am J Gastro-
enterol 2007;102:2271e9. quiz 2280.
102. Assa'ad AH, Putnam PE, Collins MH, Akers RM, Jameson SC, Kirby CL, et al.
Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy
Clin Immunol 2007;119:731e8.
103. Chang JY, Choung RS, Lee RM, Locke 3rd GR, Schleck CD, Zinsmeister AR, et al.
A shift in the clinical spectrum of eosinophilic gastroenteritis toward the
mucosal disease type. Clin Gastroenterol Hepatol 2010;8:669e75. quiz e688.
104. Kalantar SJ, Marks R, Lambert JR, Badov D, Talley NJ. Dyspepsia due to
eosinophilic gastroenteritis. Dig Dis Sci 1997;42:2327e32.
105. Kellermayer R, Tatevian N, Klish W, Shulman RJ. Steroid responsive eosino-
philic gastric outlet obstruction in a child. World J Gastroenterol 2008;14:
2270e1.
106. Mazokopakis E, Vrentzos G, Spanakis E, Tzardi M, Katrinakis G, Diamantis I.
A case of eosinophilic gastroenteritis with severe peripheral eosinophilia. Mil
Med 2006;171:331e2.
107. Moore D, Lichtman S, Lentz J, Stringer D, Sherman P. Eosinophilic gastroen-
teritis presenting in an adolescent with isolated colonic involvement. Gut
1986;27:1219e22.
108. Owen-Smith MS. Eosinophilic gastroenteritis. Aust N Z J Surg 1975;45:
257e60.
109. Sandrasegaran K, Rajesh A, Maglinte DD. Eosinophilic gastroenteritis pre-
senting as acute abdomen. Emerg Radiol 2006;13:151e4.
110. Siewert E, Lammert F, Koppitz P, Schmidt T, Matern S. Eosinophilic gastro-
enteritis with severe protein-losing enteropathy: successful treatment with
budesonide. Dig Liver Dis 2006;38:55e9.
111. Tan AC, Kruimel JW, Naber TH. Eosinophilic gastroenteritis treated with non-
enteric-coated budesonide tablets. Eur J Gastroenterol Hepatol 2001;13:
425e7.
112. Whitaker IS, Gulati A, McDaid JO, Bugajska-Carr U, Arends MJ. Eosinophilic
gastroenteritis presenting as obstructive jaundice. Eur J Gastroenterol Hepatol
2004;16:407e9.
113. Caldwell JH, Sharma HM, Hurtubise PE, Colwell DL. Eosinophilic gastroen-
teritis in extreme allergy. Immunopathological comparison with nonallergic
gastrointestinal disease. Gastroenterology 1979;77:560e4.
114. Copeland BH, Aramide OO, Wehbe SA, Fitzgerald SM, Krishnaswamy G.
Eosinophilia in a patient with cyclical vomiting: a case report. Clin Mol Allergy
2004;2:7.
115. Dobbins JW, Sheahan DG, Behar J. Eosinophilic gastroenteritis with esopha-
geal involvement. Gastroenterology 1977;72:1312e6.
116. Everett GD, Mitros FA. Eosinophilic gastroenteritis with hepatic eosinophilic
granulomas. Report of a case with 30-year follow-up. Am J Gastroenterol
1980;74:519e21.
117. Goldman H, Proujansky R. Allergic proctitis and gastroenteritis in children.
Clinical and mucosal biopsy features in 53 cases. Am J Surg Pathol 1986;10:
75e86.
118. Goldstein NA, Putnam PE, Dohar JE. Laryngeal cleft and eosinophilic gastro-
enteritis: report of 2 cases. Arch Otolaryngol Head Neck Surg 2000;126:
227e30.
119. Harmon WA, Helman CA. Eosinophilic gastroenteritis and ascites. J Clin Gas-
troenterol 1981;3:371e3.
120. Hoefer RA, Ziegler MM, Koop CE, Schnaufer L. Surgical manifestations of
eosinophilic gastroenteritis in the pediatric patient. J Pediatr Surg 1977;12:
955e62.
J. Ito et al. / Allergology International 64 (2015) 253e259 259121. Levinson JD, Ramanathan VR, Nozick JH. Eosinophilic gastroenteritis with
ascites and colon involvement. Am J Gastroenterol 1977;68:603e7.
122. McCrory WW, Becker CG, Cunningham-Rundles C, Klein RF, Mouradian J,
Reisman L. Immune complex glomerulopathy in a child with food hyper-
sensitivity. Kidney Int 1986;30:592e8.
123. Peterson NE, Silverman A, Campbell JB. Eosinophilic cystitis and coexistent
eosinophilic gastroenteritis in an infant. Pediatr Radiol 1989;19:484e5.
124. Robert F, Omura E, Durant JR. Mucosal eosinophilic gastroenteritis with sys-
temic involvement. Am J Med 1977;62:139e43.
125. Rochester D, Winans CS, Riddell RH. Circumscribed eosinophilic gastroen-
teritis. Rev Interam Radiol 1979;4:195e8.
126. Rumans MC, Lieberman DA. Eosinophilic gastroenteritis presenting with
biliary and duodenal obstruction. Am J Gastroenterol 1987;82:775e8.
127. Schulze K, Mitros FA. Eosinophilic gastroenteritis involving the ileocecal area.
Dis Colon Rectum 1979;22:47e50.
128. Thomas E, Lev R, McCahan JF, Pitchumoni CS. Eosinophilic gastroenteritis with
malabsorption, extensive villous atrophy, recurrent hemorrhage and chronic
pulmonary ﬁbrosis. Am J Med Sci 1975;269:259e65.
129. Trounce JQ, Tanner MS. Eosinophilic gastroenteritis. Arch Dis Child 1985;60:
1186e8.
130. Abe Y, Iijima K, Ohara S, Koike T, Ara N, Uno K, et al. A Japanese case series of
12 patients with esophageal eosinophilia. J Gastroenterol 2011;46:25e30.
131. Fujishiro H, Amano Y, Kushiyama Y, Ishihara S, Kinoshita Y. Eosinophilic
esophagitis investigated by upper gastrointestinal endoscopy in Japanese
patients. J Gastroenterol 2011;46:1142e4.
132. Jingsheng Z, Yuncheng L, Yingye M, Hao L, Congyang L. The mural form of
eosinophilic esophagitis is accompanied by superﬁcial esophageal squamous
cell carcinoma. Case Rep Pathol 2012;2012:315428.
133. Joo MK, Park JJ, Kim SH, Kim KH, Jung W, Yun JW, et al. Prevalence and
endoscopic features of eosinophilic esophagitis in patients with esophageal or
upper gastrointestinal symptoms. J Dig Dis 2012;13:296e303.134. Kim NI, Jo Y, Ahn SB, Son BK, Kim SH, Park YS, et al. A case of eosinophilic
esophagitis with food hypersensitivity. J Neurogastroenterol Motil 2010;16:
315e8.
135. Sandhya P, Danda D, Mathew J, Kurian S, Ramakrishna BS. Eosinophilic
esophagitis and pharyngitis presenting as mass lesion in a patient with
inactive rheumatoid arthritis. J Clin Rheumatol 2012;18:33e5.
136. Shi YN, Sun SJ, Xiong LS, Cao QH, Cui Y, Chen MH. Prevalence, clinical man-
ifestations and endoscopic features of eosinophilic esophagitis: a pathological
review in China. J Dig Dis 2012;13:304e9.
137. Al-Hussaini AA, Semaan T, El Hag IA. Esophageal trachealization: a feature of
eosinophilic esophagitis. Saudi J Gastroenterol 2009;15:193e5.
138. Furuta K, Adachi K, Kowari K, Mishima Y, Imaoka H, Kadota C, et al. A Japanese
case of eosinophilic esophagitis. J Gastroenterol 2006;41:706e10.
139. Lu HC, Lu CL, Chang FY. Eosinophilic esophagitis in an asymptomatic Chinese.
J Chin Med Assoc 2008;71:362e4.
140. Zink DA, Amin M, Gebara S, Desai TK. Familial dysphagia and eosinophilia.
Gastrointest Endosc 2007;65:330e4.
141. Fujiwara H, Morita A, Kobayashi H, Hamano K, Fujiwara Y, Hirai K, et al.
Inﬁltrating eosinophils and eotaxin: their association with idiopathic eosin-
ophilic esophagitis. Ann Allergy Asthma Immunol 2002;89:429e32.
142. Jawairia M, Shahzad G, Singh J, Rizvon K, Mustacchia P. A case report of
eosinophilic esophagitis accompanying hypereosinophilic syndrome. Case Rep
Gastrointest Med 2012;2012:683572.
143. Alnaser S, Aljebreen AM. Endoscopic ultrasound and hisopathologic correlates
in eosinophilic gastroenteritis. Saudi J Gastroenterol 2007;13:91e4.
144. Jaimes-Hernandez J, Aranda-Peirera P, Melendez-Mercado CI. Eosinophilic
enteritis in association with systemic lupus erythematosus. Lupus 2009;18:
452e6.
145. Milman PJ, Sidhu GS. Case report: eosinophilic gastritis simulating a
neoplasm. Am J Med Sci 1978;276:227e30.
